Brookfield Corp’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Brookfield Corp’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-122,207	Closed	-$920K	–	485
2023 Q2	$920K	Sell	122,207 -314,897	-72%	-$2.55M	﹤0.01%	472
2023 Q1	$3.87M	Buy	+437,104	New	+$4.32M	0.01%	335
2022 Q3	–	Sell	-597,122	Closed	-$4.49M	–	767
2022 Q2	$4.49M	Buy	597,122 +12,276	+2%	+$107K	0.02%	280
2022 Q1	$5.49M	Buy	+584,846	New	+$4.88M	0.02%	243

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

IAM

Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Brookfield Corp's TEVA Position: Q3 2023 in Review

Brookfield Corp sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q3 2023, closing a stake of 122,207 shares — an estimated $920K sold.

Brookfield Corp first reported a position in TEVA in Q1 2022 and held it in 4 quarters. The position peaked at $5.49M in Q1 2022. 435 funds tracked by Wall St. Rank hold TEVA as of Q3 2023.

Brookfield Corp reported no remaining Teva Pharmaceutical Industries Limited position as of Q3 2023 after selling out during the quarter.
Brookfield Corp sold 122,207 Teva Pharmaceutical Industries Limited shares in Q3 2023, an estimated $920K.
Brookfield Corp first reported a position in Teva Pharmaceutical Industries Limited in Q1 2022 and held it in 4 quarters.
Brookfield Corp's Teva Pharmaceutical Industries Limited position peaked at $5.49M in Q1 2022.
435 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2023.

Based on Brookfield Corp's 13F filing for Q3 2023, filed 14 Nov 2023.